Skip to main content
Home

Language & Country Selector for Desktop

language-selector-globe United States | en

Choose Location

  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
  • Argentina | es
  • Brazil | pt
  • Canada | en
  • Canada | fr
  • Central America | es
  • Colombia | es
  • Latin America | es
  • Mexico | es
  • United States | en
  • Venezuela | es
  • Australia | en
  • Bangladesh | en
  • Hong Kong S.A.R. | zh
  • India | en
  • Indonesia | en
  • Japan | ja
  • Korea | ko
  • Mainland China | zh
  • Malaysia | en
  • Pakistan | en
  • Philippines | en
  • Taiwan | zh
  • Austria | de
  • Belgium | fr
  • Belgium | nl
  • Bulgaria | bg
  • Czech Republic | cs
  • Czech Republic | en
  • Denmark | da
  • Estonia | et
  • Finland | fi
  • France | fr
  • Germany | de
  • Greece | el
  • Hungary | hu
  • Ireland | en
  • Italy | it
  • Latvia | lv
  • Lithuania | lt
  • Netherlands | nl
  • Norway | no
  • Poland | pl
  • Portugal | pt
  • Romania | ro
  • Russia | ru
  • Serbia | sr
  • Singapore | en
  • Slovakia | sk
  • Spain | es
  • Sweden | sv
  • Switzerland | de
  • Switzerland | fr
  • United Kingdom | en
  • Global | en
  • Novartis Foundation | en
  • Sandoz | en
  • Egypt | en
  • South Africa | en
  • Turkey | tr

Language & Country Selector for Mobile

language-selector-globe US

Choose Location

Americas Asia Pacific Europe International Middle East & Africa
  • Argentina | es
  • Australia | en
  • Austria | de
  • Bangladesh | en
  • Belgium | fr
  • Belgium | nl
  • Brazil | pt
  • Bulgaria | bg
  • Canada | en
  • Canada | fr
  • Central America | es
  • Colombia | es
  • Czech Republic | cs
  • Czech Republic | en
  • Denmark | da
  • Egypt | en
  • Estonia | et
  • Finland | fi
  • France | fr
  • Germany | de
  • Global | en
  • Greece | el
  • Hong Kong S.A.R. | zh
  • Hungary | hu
  • India | en
  • Indonesia | en
  • Ireland | en
  • Italy | it
  • Japan | ja
  • Korea | ko
  • Latin America | es
  • Latvia | lv
  • Lithuania | lt
  • Mainland China | zh
  • Malaysia | en
  • Mexico | es
  • Netherlands | nl
  • Norway | no
  • Novartis Foundation | en
  • Pakistan | en
  • Philippines | en
  • Poland | pl
  • Portugal | pt
  • Romania | ro
  • Russia | ru
  • Sandoz | en
  • Serbia | sr
  • Singapore | en
  • Slovakia | sk
  • South Africa | en
  • Spain | es
  • Sweden | sv
  • Switzerland | de
  • Switzerland | fr
  • Taiwan | zh
  • Turkey | tr
  • United Kingdom | en
  • United States | en
  • Venezuela | es
    • About 
      • Novartis in the US 
        • Company at a Glance 
        • By the Numbers 
        • Diversity and Inclusion 
        • Pay Transparency-EPIC 
        • Our Code of Ethics 
      • Strategy 
      • Diversity and Inclusion 
        • Ensuring Equity 
        • The Spirit of Inclusivity 
        • Toward a better society 
        • Parental Leave 
        • Standing for Racial Equity and Justice as One Novartis 
        • Novartis US EEO / D&I Report 2021 
        • Supplier Diversity 
      • People and Culture 
      • Products 
      • Country Leadership Team 
      • External Funding 
      • Contact Us 
      Woman scientist in lab About
    • Patients and Caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Patient Assistance 
      • Diseases 
      • Participating in Clinical Trials 
      • Patient Perspectives 
      • Adverse Event Reporting 
      • The STEP Program 
        • Sickle Cell Disease (SCD) 
        • Program Overview 
        • Multiple Sclerosis (MS) 
        • Cancer 
        • Application for Funding to Help Address Health Disparities 
        • Health Disparities 
      Patient smiling at doctor image Patients and Caregivers
    • Healthcare Professionals 
      • Novartis Pipeline 
      • Novartis Clinical Trials 
      • Adverse Event Reporting 
      Two doctors examining X-ray Healthcare Professionals
    • ESG 
      • Ethical Behavior 
        • Code of Ethics 
        • SpeakUp 
        • PhRMA Code on Interactions with Healthcare Professionals 
        • Business Principles 
      • Ethics, Risk and Compliance 
        • Compliance Program 
        • State Laws 
        • Corporate Integrity Agreement 
        • Payments to HCPs & HCOs 
        • Enhanced Verification Request 
      • Corporate Responsibility 
        • Population Health 
        • Novartis in Society US Reports 
        • Novartis US Foundation 
        • Environmental Sustainability 
        • People and Communities 
      • Beacon of Hope 
        • Beacon of Hope: Measurable solutions for health equity 
      Novartis East Hanover Campus Landscaping ESG
    • News 
      • News Archive 
      • Statements 
      • Stories 
      • Contacts 
      Co-workers having a meeting News
    • Careers 
      • Career Search 
      • Meet the Teams 
      • Early Career 
      • Personal Growth 
      • How We Work 
      • Employee Benefits 
      • Diversity and Inclusion 
      • Awards & Recognition 
      Meeting in Atrium Careers
    • Coronavirus 
      coronavirus covid 19 hero image_0 Coronavirus
    Novartis East Hanover Campus East Village Promenade Home

Stories

Story Navigation
  • All Topics
  • Medicines
  • Discovery
  • Hope
  • Global Impact
  • Education & Awareness
icon
  • ripples in water 1600x800 stripe image_0
    Education and Awareness
    Social CommitmentWorking at Novartis
    Jul 20, 2022
    Our Collective Commitment to a DEI Movement

    The Novartis 2022 Day of Reflection highlighted the company’s commitment to making DEI a movement not a moment.

    Education and Awareness
  • ripples in water 1440x546 image_0
    Education and Awareness
    Social CommitmentWorking at Novartis
    Mar 13, 2022
    Learning, Connecting and Moving Forward Together

    At Novartis, our common humanity is what connects all of us. We will continue to stand in solidarity with all people who find themselves in the path of injustice, inequity or violence. The Day of Reflection, Forward Together is an opportunity for everyone to engage in listening and learning.

    Education and Awareness
  • tree roots with green leaves image_0
    Hope
    Access to HealthcareFuture of HealthcareLocal ImpactSocial Commitment
    Mar 13, 2022
    Addressing health inequities starts by looking within

    The Novartis US Foundation has partnered with the Institute for Healthcare Improvement to help healthcare systems better serve patients.

    Hope
  • odysight mobile app hero 1 image_0
    Education and Awareness
    DigitalEye CareMobile DevicesOphthalmologyReimagine Medicine
    Mar 13, 2022
    At-home app helps patients stay engaged and adherent to vision monitoring remotely

    Novartis begins U.S. pilot program for OdySight, a clinically tested mobile application designed to help monitor vision remotely.

    Education and Awareness
  • story rock layers image_0
    Education and Awareness
    Access to HealthcareClinical TrialsFuture of Healthcare
    Mar 13, 2022
    Building clinical trial diversity for long-term equity

    Vas Narasimhan reflects on how to increase diversity in clinical trials

    Education and Awareness
  • pledge illustration image_0
    Education and Awareness
    Cardiovascular DiseaseDisease AwarenessLiving With DiseasePatient Voices
    Mar 13, 2022
    Understanding Heart Health Inequities During Black History Month

    After years of decline, cardiovascular disease mortality is on the rise, with a disproportionate impact on Black Americans

    Education and Awareness
  • reimagining healthcare hero image_0
    Global Impact
    Access to HealthcareSocial Commitment
    Mar 13, 2022
    Reimagining Healthcare in Challenging Times: Novartis in Society US Report for 2020

    Novartis is striving every day to help patients, strengthen communities, drive sustainability and build a more equitable healthcare system for all.

    Global Impact
  • doctor ipad hero image_0
    Education and Awareness
    Access to HealthcareEmerging TechnologyFuture of HealthcareLocal ImpactReimagine Medicine
    Mar 13, 2022
    Telemedicine is helping patients in underserved communities access quality healthcare

    The Novartis US Foundation partners with local groups to improve healthcare in underserved communities, including by expanding use of telemedicine.

    Education and Awareness
  • two novartis researchers collaborating image_0
    Hope
    Access to HealthcareBiomedical ResearchDiseasesGlobal Health PartnershipsSocial Commitment
    Mar 13, 2022
    Working Together at Novartis to Fight COVID-19 and Help People in Need

    Novartis is fighting COVID-19 broadly, from committing R&D resources to better understand and treat the disease to reaching out to individuals and communities in need.

    Hope
  • scientists discussion data hero image_0
    Medicines
    Biomedical JobsData ScienceDigitalNext Generation Scientist
    Mar 13, 2022
    Novartis looks to the brightest academic minds to reimagine metastatic breast cancer treatment

    More than 16 teams from US universities participated in the first US oncology data science hackathon to tackle current challenges in metastatic breast cancer treatments.

    Medicines
  • graphical representation diversity image_0
    Education and Awareness
    Working at Novartis
    Mar 13, 2022
    Day of Reflection at Novartis

    On this Day of Reflection, Novartis associates are thinking and talking about what it means to be part of a truly diverse and inclusive organization.

    Education and Awareness
  • shaping future sickle cell disease hero image_0
    Discovery
    Mar 13, 2022
    Shaping the future of sickle cell disease

    Collaborations are driving advances in sickle cell disease research, bringing new hope to patients.

    Discovery

Pagination

  • 1
  • 2
  • › Next page

Novartis United States

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • News
  • Careers
Media Center
  • News Archive
  • Statements
  • Stories
Our Portfolio
  • Novartis Clinical Pipeline
  • Novartis Product Portfolio
Other Novartis US Websites
  • Oncology HCP Resources
  • Gene Therapy Network
  • Medical Information
  • Sandoz
  • Global Site
Footer Bottom
© 2023 Novartis Pharmaceuticals Corporation
  • Terms of Use
  • Privacy Policy
  • Contacts
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for US Residents Only